Sign in to view content

Safety of Intravitreal Pegcetacoplan in Geographic Atrophy: Results from the Phase 3 DERBY and OAKS Trials

David S. Boyer, MD

Video
Published 2021

Related

Safety of Intravitreal Pegcetacoplan for Geographic Atrophy: 12-Month Results of the OAKS and DERBY Trials
Caroline Baumal, MD
Annual Meeting Talks
2022
Phase IIIb TALON study of brolucizumab versus aflibercept in a matched treat-and-extend regimen to treat neovascular AMD: 32-week primary outcomes
Carl D. Regillo, MD
Annual Meeting Talks
2022
Vitreoretinal Interface Disease In the Setting of AMD
Andrew A. Moshfeghi, MD, MBA, FASRS
Updates from the Field
2019

Category: AMD-Non-Neovascular

See more